Authors





Vicki Fung, PhD

Latest:

Premium Tax Credits in the American Rescue Plan and Off-Marketplace Enrollees

We estimate that the median 2021 premium tax credit for off-marketplace enrollees in California would be $311 if they switched to marketplace plans, with wide variation by age and plan size.


Alexander C. Marshall, PharmD, MPH

Latest:

Humanistic and Economic Burden of Hepatocellular Carcinoma: Systematic Literature Review

Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.


James Baumgardner, PhD

Latest:

Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.


Michael E. Porter, PhD, MBA

Latest:

A Blueprint for Pharmacy Benefit Managers to Increase Value

Pharmacy benefit managers can increase value through promoting use of cost-effective medications, timely initiation of essential therapy, and adherence to that therapy.





C. David Klingman, PhD

Latest:

Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients

A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.






Michael Shwartz, PhD

Latest:

How Pooling Fragmented Healthcare Encounter Data Affects Hospital Profiling

Incomplete records of patient history can bias hospital profiling. Completing health records for Medicare-covered patients in VA hospitals resulted in modest changes in hospital performance.


Stoddard Davenport, BA

Latest:

Population Health in Primary Care: Cost, Quality, and Experience Impact

An evaluation of the use of predictive modeling for primary care resource allocation demonstrated reduced spending and improved quality and patient experience for publicly insured adults.




Michael P. Dorsch, PharmD, MS

Latest:

Costs of Providing Antiplatelet Medication for Percutaneous Coronary Intervention Patients

An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers.


Diane K. Griffith, LMSW, ACSW

Latest:

A Multidisciplinary Intervention for Reducing Readmissions Among Older Adults in a Patient-Centered Medical Home

A collaborative practice model to reduce hospital readmissions from an outpatient environment.


James H. Jackson, PharmD, MPH

Latest:

Provider Organization Performance Assessment Utilizing Diabetes Physician Recognition Program

Retrospective chart review to assess the impact of the Diabetes Physician Recognition Program showed that most patients achieved control levels recommended by national treatment guidelines.



Daniel A. Waxman, MD, PhD

Latest:

Does Medicare Advantage Enrollment Affect Home Healthcare Use?

Medicare Advantage beneficiaries use less home healthcare than do their fee-for-service counterparts, but there is marked regional variation in use by both groups.



Andrew J. Nowalk, MD, PhD

Latest:

Economics of Influenza Vaccine Administration Timing for Children

Vaccinating children earlier (ie, September or October) can provide net economic benefit to society and to third-party payers. Vaccination of children remained cost-effective through December.





AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo